Skip to main content
Elsevier Sponsored Documents logoLink to Elsevier Sponsored Documents
. 2024 Oct 3;42(23):None. doi: 10.1016/j.vaccine.2024.06.056

Corrigendum to “Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023–January 2024” [Vaccine 42(19) (2024)]

Charlotte Laniece Delaunay a, Aryse Melo b, Marine Maurel a, Clara Mazagatos c, Luise Goerlitz d, Joan O’Donnell e, Beatrix Oroszi f, Noémie Sève g, Ana Paula Rodrigues h, Iván Martínez-Baz i, Adam Meijer j, Ivan Mlinarić k, Neus Latorre-Margalef l, Mihaela Lazăr m, Gloria Pérez-Gimeno c, Ralf Dürrwald n, Charlene Bennett o, Gergő Túri f, Marie-Anne Rameix-Welti p,q, Raquel Guiomar b, Jesús Castilla i, Mariëtte Hooiveld r, Sanja Kurečić Filipović k, Tove Samuelsson Hagey l, Frederika Dijkstra j, Vitor Borges s, Violeta Ramos Marín t, Sabrina Bacci u, Marlena Kaczmarek u, Esther Kissling a,; European primary care VE group, on behalf of the
PMCID: PMC11413480  PMID: 38971666

The authors regret that there was an error in two dates in Table 1, which includes autumn 2023 national COVID-19 vaccination campaign dates by study site. We update here the date for Germany, which was 18 September 2023, and for Navarre, Spain, which was 16 October, 2023. These dates were used in the analysis, so the error in Table 1 does not affect results or findings. The corrected Table 1 is as follows:

Table 1. Autumn 2023 national COVID-19 vaccination campaign, vaccination and recruitment information, by study site, VEBIS primary care study, September 2023–January 2024

Study sites included in the analysis Start of autumn 2023 national COVID-19 vaccination campaigns Age-specific recommendation for COVID-19 vaccination for older adults Data source for COVID-19 vaccination information Case definition used for recruitment of patientsb
Croatia 18 Sep 2023 65 Medical records, vaccination registry, GP interview (self-report) EU-ILI or EU-ARI
France 2 Oct 2023 65 GP interview (self-report) Sentinelles ARI
Germany 18 Sep 2023 60 Medical records, patient’s certificate of vaccination, GP interview (self-report) ARI
Hungary 1 Oct 2023 60 National Immunisation Registry (83.5%), GP records, self-report EU-ARI
Ireland 2 Oct 2023 50 Data linkage to vaccine registry EU-ARI
The Netherlands 2 Oct 2023 60 GP interview (self-report) EU-ILI or EU-ARI
Portugal 29 Sep 2023 60 Vaccine registry look-up by GPs EU-ARI
Spain, national 25 Sep 2023 60 Data linkage to vaccine registry EU-ARI
Spain, Navarre region c 16 Oct 2023 60 Data linkage to vaccine registry EU-ILI
Sweden 7 Nov 2023 65 Data linkage to vaccine registry EU-ARI

ARI: acute respiratory infection; EU: European Union; ILI: influenza-like illness; VEBIS: Vaccine Effectiveness, Burden and Impact Studies.

a Romania was excluded from the analysis due to too small a sample size (<10 cases).

b EU-ARI: Sudden onset of symptoms and at least one of four respiratory symptoms (cough, sore throat, shortness of breath, coryza) and a clinician’s judgement that the illness is due to an infection; EU-ILI: Sudden onset of symptoms and at least one of four systemic symptoms (fever or feverishness, malaise, headache, or myalgia) and at least one of three respiratory symptoms (cough, sore throat, or shortness of breath); Sentinelles ARI: Sudden onset of fever (or feverishness), and respiratory signs; The ARI case definition in Germany includes patients with at least one of the following four symptoms: fever, cough, coryza or sore throat.

c Some vaccination may have taken place from 25 September 2023.

The authors would like to apologise for this oversight and for any inconvenience caused.

RESOURCES